We thus assume that the differentiation of TAMs selectively observed in OVA expressing B16F10/M2KO/OVA tumors was caused by IFNγ released from CD4+ Th1 cells as a consequence of tumor antigen-specific TAM / CD4+ Th1 interaction in vivo. This evidence concerns the gene IFNG and neoplasm.